Latest News about NVS
Recent news which mentions NVS
   Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
   
  
  
  April 16, 2024
  From Benzinga
 
   Looking for an Easy Way to Earn Passive Income? This Vanguard ETF Pays a Dividend Yield of Nearly 4.9%.
   
  
  
  April 14, 2024
  From Motley Fool
 
   Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
   
  
  
  April 11, 2024
  From Benzinga
 
   Why Is Kidney Disease-Focused Alpine Immune Sciences Stock Trading Higher On Wednesday?
   
  
  
  April 10, 2024
  From Benzinga
 From InvestorPlace
 
   Jack Ma Is Giving Alibaba (BABA) Stock a Big Boost
   
  
  
  April 10, 2024
  From InvestorPlace
 From InvestorPlace
 From Benzinga
 From Benzinga
 
   Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
   
  
  
  April 08, 2024
  From Benzinga
 
   Why Is Novartis Stock Trading Higher On Thursday?
   
  
  
  April 04, 2024
  From Benzinga
 
   Harnessing AI for Drug Discovery: Top 3 Stocks to Watch
   
  
  
  March 26, 2024
  From InvestorPlace
 From Benzinga
 
   Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge
   
  
  
  March 22, 2024
  From Benzinga
 From Benzinga
 
   Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
   
  
  
  March 19, 2024
  From Benzinga
 
   FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
   
  
  
  March 15, 2024
  From Benzinga
 
   Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
   
  
  
  March 11, 2024
  From Benzinga
 
   3 Dividend Stocks to Buy Hand Over Fist in March
   
  
  
  March 10, 2024
  From Motley Fool
 
   FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
   
  
  
  March 08, 2024
  From Benzinga
 
   Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029
   
  
  
  March 07, 2024
  From Benzinga
 
   Biogen's Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers
   
  
  
  March 06, 2024
  From Benzinga
 
   Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic
   
  
  
  March 05, 2024
  From Benzinga
 
   Novartis Reveals Promising Gene Therapy Data for Treating Spinal Muscular Atrophy in Older Children
   
  
  
  March 04, 2024
  From Benzinga
 
   3 Stocks Primed for Exponential Returns by 2034
   
  
  
  March 01, 2024
  From InvestorPlace
 
   2 Dividend Stocks to Buy and Hold Forever
   
  
  
  February 29, 2024
  From Motley Fool
 
   11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
   
  
  
  February 28, 2024
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
